TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 95 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $31,000 | -18.4% | 23,352 | -31.4% | 0.00% | – |
| Q4 2018 | $38,000 | -97.3% | 34,038 | -93.2% | 0.00% | – |
| Q3 2018 | $1,385,000 | +51.9% | 501,665 | +96.4% | 0.00% | – |
| Q2 2018 | $912,000 | +5.2% | 255,400 | -9.6% | 0.00% | – |
| Q1 2018 | $867,000 | -29.1% | 282,368 | +45.4% | 0.00% | – |
| Q4 2017 | $1,223,000 | +4.7% | 194,226 | +13.7% | 0.00% | – |
| Q3 2017 | $1,168,000 | -54.4% | 170,800 | -52.4% | 0.00% | -100.0% |
| Q2 2017 | $2,561,000 | +112.0% | 359,200 | +173.4% | 0.00% | 0.0% |
| Q1 2017 | $1,208,000 | +143.1% | 131,400 | +6.4% | 0.00% | – |
| Q4 2016 | $497,000 | +40.0% | 123,453 | +33.0% | 0.00% | – |
| Q3 2016 | $355,000 | +14.5% | 92,800 | +28.9% | 0.00% | – |
| Q2 2016 | $310,000 | -73.8% | 72,017 | -71.8% | 0.00% | – |
| Q1 2016 | $1,184,000 | -51.9% | 255,611 | +4.1% | 0.00% | – |
| Q4 2015 | $2,463,000 | -52.2% | 245,544 | -64.4% | 0.00% | -100.0% |
| Q3 2015 | $5,151,000 | -59.3% | 690,498 | +159.1% | 0.00% | -60.0% |
| Q2 2015 | $12,645,000 | +87.0% | 266,541 | +44.4% | 0.01% | +25.0% |
| Q1 2015 | $6,762,000 | +23.6% | 184,544 | +33.9% | 0.00% | +33.3% |
| Q4 2014 | $5,472,000 | +102.1% | 137,778 | +1.5% | 0.00% | – |
| Q3 2014 | $2,707,000 | +140.0% | 135,684 | +62.3% | 0.00% | – |
| Q2 2014 | $1,128,000 | +506.5% | 83,618 | +390.5% | 0.00% | – |
| Q1 2014 | $186,000 | +144.7% | 17,046 | +57.1% | 0.00% | – |
| Q2 2013 | $76,000 | – | 10,848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
| Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
| Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
| Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
| Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
| EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
| Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
| TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |